SKI Market

Indian Indices

Sensex

77,566.16 -1,352.74
( -1.71%)

Global Indices

Nasdaq

47,518.20 -457.55
(-0.95%)

Dow Jones

6,761.35 -90.36
(-1.32%)

Hang Seng

52,808.52 -2,812.32
(-5.06%)

Nikkei 225

10,249.54 -35.21
(-0.34%)

Forex

USD-INR

91.74 -0.39
(-0.42%)

EUR-INR

106.47 -0.59
(-0.55%)

GBP-INR

122.42 -0.61
(-0.50%)

JPY-INR

0.58 0.00
(-0.46%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Anthem Biosciences Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

544449

INE0CZ201020

50.8006126

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ANTHEM

61.9

37132.09

EPS(TTM)

Face Value()

Div & Yield %

10.68

Particulars(INCOME)	Mar 2025 ( Cr)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)
Sales Turnover	1840.65	1417.54	1056.92	1231.26	1103.24	632.72
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	1840.65	1417.54	1056.92	1231.26	1103.24	632.72
Other Income	109.44	70.52	139.17	48.98	37.21	20.76
Stock Adjustments	86.70	41.23	9.01	1.37	-39.12	37.86
Total Income	2036.79	1529.29	1205.10	1281.61	1101.33	691.34
EXPENDITURE :
Raw Materials	828.08	640.77	348.29	410.30	407.88	284.29
Power & Fuel Cost	42.56	31.29	38.95	36.32	34.23	30.42
Employee Cost	251.76	182.65	153.24	137.51	142.19	120.15
Other Manufacturing Expenses	46.27	34.13	21.11	23.38	22.76	14.46
Selling & Administrative Expenses	56.41	54.67	60.66	48.21	33.66	31.83
Miscellaneous Expenses	13.08	10.25	12.68	11.46	15.67	7.52
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	1238.15	953.77	634.92	667.18	656.38	488.66
Operating Profit	798.65	575.52	570.19	614.44	444.95	202.68
Interest	9.29	9.26	8.71	10.09	16.97	20.43
Gross Profit	789.36	566.26	561.48	604.35	427.98	182.25
Depreciation	77.94	81.49	63.70	57.76	62.40	61.58
Profit Before Tax	711.42	484.77	497.78	546.59	365.58	120.67
Tax	182.03	126.41	120.05	142.39	96.70	33.25
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	23.21	-16.42	-7.94	-1.79	-2.43	-5.29
Reported Net Profit	506.19	374.78	385.67	405.99	271.31	92.70
Extraordinary Items	-0.26	-0.21	40.84	-0.14	-0.14	0.06
Adjusted Net Profit	506.45	374.99	344.83	406.13	271.45	92.64
Adjustment below Net Profit	-50.62	-71.60	-139.35	0.00	0.00	0.00
P & L Balance brought forward	1524.15	1220.97	974.65	568.66	362.71	270.38
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	26.08	0.37
P & L Balance carried down	1979.72	1524.15	1220.97	974.65	607.93	362.71
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	9.05	6.70	6.76	462.60	319.76	110.63
Earnings Per Share(Adj)-Unit Curr	9.05	6.70	6.76	462.60	319.76	110.63
Book Value-Unit Curr	44.24	34.58	30.53	1544.46	826.76	503.43
Book Value(Adj)-Unit Curr	44.24	34.58	30.53	1544.46	826.76	503.43

77,566.16 -1,352.74 ( -1.71%)

47,518.20 -457.55 (-0.95%)

6,761.35 -90.36 (-1.32%)

52,808.52 -2,812.32 (-5.06%)

10,249.54 -35.21 (-0.34%)

91.74 -0.39 (-0.42%)

106.47 -0.59 (-0.55%)

122.42 -0.61 (-0.50%)

0.58 0.00 (-0.46%)